Previous Article | Next Article 
Journal of Virology, December 2001, p. 12439-12445, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12439-12445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
A Unique Heparin-Binding Domain in the Envelope
Protein of the Neuropathogenic PVC-211 Murine Leukemia Virus May
Contribute to Its Brain Capillary Endothelial Cell Tropism
Atsushi
Jinno-Oue,
Miho
Oue, and
Sandra K.
Ruscetti*
Basic Research Laboratory, National Cancer
Institute
Frederick, Frederick, Maryland 21702-1201
Received 11 May 2001/Accepted 4 September 2001
Previous studies from our laboratory demonstrated that PVC-211
murine leukemia virus (MuLV), a neuropathogenic variant of Friend MuLV
(F-MuLV), had undergone genetic changes which allowed it to efficiently
infect rat brain capillary endothelial cells (BCEC) in vivo and in
vitro. Two amino acid changes from F-MuLV in the putative receptor
binding domain (RBD) of the envelope surface protein of PVC-211 MuLV
(Glu-116 to Gly and Glu-129 to Lys) were shown to be sufficient for
conferring BCEC tropism on PVC-211 MuLV. Recent examination of the
unique RBD of PVC-211 MuLV revealed that the substitution of Lys for
Glu at position 129 created a new heparin-binding domain that
overlapped a heparin-binding domain common to ecotropic MuLVs. In this
study we used heparin-Sepharose columns to demonstrate that PVC-211
MuLV, but not F-MuLV, can bind efficiently to heparin and that one or
both of the amino acids in the RBD of PVC-211 MuLV that are associated
with BCEC tropism are responsible. We further showed that heparin can
enhance or inhibit MuLV infection and that the mode of action is
dependent on heparin concentration, sulfation of heparin, and the
affinity of the virus for heparin. Our results suggest that the amino
acid changes that occurred in the envelope surface protein of PVC-211 MuLV may allow the virus to bind strongly to the surface of BCEC via
heparin-like molecules, increasing the probability that the virus will
bind to its cell surface receptor and efficiently infect these cells.
*
Corresponding author. Mailing address: Basic Research
Laboratory, Building 469, Room 205, National Cancer
Institute
Frederick, Frederick, MD 21702-1201. Phone: (301) 846-5740. Fax: (301) 846-6164. E-mail: ruscetti{at}ncifcrf.gov.
Journal of Virology, December 2001, p. 12439-12445, Vol. 75, No. 24
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.24.12439-12445.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Li, X., Hanson, C., Cmarik, J. L., Ruscetti, S.
(2009). Neurodegeneration Induced by PVC-211 Murine Leukemia Virus Is Associated with Increased Levels of Vascular Endothelial Growth Factor and Macrophage Inflammatory Protein 1{alpha} and Is Inhibited by Blocking Activation of Microglia. J. Virol.
83: 4912-4922
[Abstract]
[Full Text]
-
Prestwood, T. R., Prigozhin, D. M., Sharar, K. L., Zellweger, R. M., Shresta, S.
(2008). A Mouse-Passaged Dengue Virus Strain with Reduced Affinity for Heparan Sulfate Causes Severe Disease in Mice by Establishing Increased Systemic Viral Loads. J. Virol.
82: 8411-8421
[Abstract]
[Full Text]
-
Oliveira, N. M., Satija, H., Kouwenhoven, I. A., Eiden, M. V.
(2007). Changes in viral protein function that accompany retroviral endogenization. Proc. Natl. Acad. Sci. USA
104: 17506-17511
[Abstract]
[Full Text]
-
Lee, E., Wright, P. J., Davidson, A., Lobigs, M.
(2006). Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination.. J. Gen. Virol.
87: 2791-2801
[Abstract]
[Full Text]
-
Jones, K. S., Petrow-Sadowski, C., Bertolette, D. C., Huang, Y., Ruscetti, F. W.
(2005). Heparan Sulfate Proteoglycans Mediate Attachment and Entry of Human T-Cell Leukemia Virus Type 1 Virions into CD4+ T Cells. J. Virol.
79: 12692-12702
[Abstract]
[Full Text]
-
Vlasak, M., Goesler, I., Blaas, D.
(2005). Human Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment. J. Virol.
79: 5963-5970
[Abstract]
[Full Text]
-
Reddi, H. V., Kumar, A. S. M., Kung, A. Y., Kallio, P. D., Schlitt, B. P., Lipton, H. L.
(2004). Heparan Sulfate-Independent Infection Attenuates High-Neurovirulence GDVII Virus-Induced Encephalitis. J. Virol.
78: 8909-8916
[Abstract]
[Full Text]
-
Murphy, S. L., Honczarenko, M. J., Dugger, N. V., Hoffman, P. M., Gaulton, G. N.
(2004). Disparate Regions of Envelope Protein Regulate Syncytium Formation versus Spongiform Encephalopathy in Neurological Disease Induced by Murine Leukemia Virus TR. J. Virol.
78: 8392-8399
[Abstract]
[Full Text]
-
Zhang, Y., Rassa, J. C., deObaldia, M. E., Albritton, L. M., Ross, S. R.
(2003). Identification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope Protein. J. Virol.
77: 10468-10478
[Abstract]
[Full Text]
-
Lu, C.-W., O'Reilly, L., Roth, M. J.
(2002). G100R Mutation within 4070A Murine Leukemia Virus Env Increases Virus Receptor Binding, Kinetics of Entry, and Viral Transduction Efficiency. J. Virol.
77: 739-743
[Abstract]
[Full Text]
-
El-Sheikh, A., Liu, C., Huang, H., Edgington, T. S.
(2002). A Novel Vascular Endothelial Growth Factor Heparin-binding Domain Substructure Binds to Glycosaminoglycans in Vivo and Localizes to Tumor Microvascular Endothelium. Cancer Res.
62: 7118-7123
[Abstract]
[Full Text]
-
Faix, P. H., Feldman, S. A., Overbaugh, J., Eiden, M. V.
(2002). Host Range and Receptor Binding Properties of Vectors Bearing Feline Leukemia Virus Subgroup B Envelopes Can Be Modulated by Envelope Sequences outside of the Receptor Binding Domain. J. Virol.
76: 12369-12375
[Abstract]
[Full Text]
-
Sandrin, V., Boson, B., Salmon, P., Gay, W., Negre, D., Le Grand, R., Trono, D., Cosset, F.-L.
(2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood
100: 823-832
[Abstract]
[Full Text]
-
Walker, S. J., Pizzato, M., Takeuchi, Y., Devereux, S.
(2002). Heparin Binds to Murine Leukemia Virus and Inhibits Env-Independent Attachment and Infection. J. Virol.
76: 6909-6918
[Abstract]
[Full Text]